Date: Sep 12th, 2018 NanoMab and King’s College London to Collaborate on Next Generation One Step Radiolabelling Shanghai, China, September 12th, 2018. NanoMab announced a collaboration with the School of Biomedical Engineering and Imaging Sciences, King’s College London for the development of next generation single step radiolabelling for 99mTc/188Re.
About AdministratorThis author has not yet filled in any details.
So far Administrator has created 15 blog entries.
Date: Aug 2nd, 2018 NanoMab and LifeArc to Collaborate on Camelid Single Domain Antibody Humanization Shanghai, China, August 2nd, 2018. NanoMab announced a collaboration with LifeArc (previously known as MRCT) for the humanization of camelid single domain antibody NM-02.
Date: March 30th, 2018 NanoMab Announces First NSCLC Patient Dosed in FIH of 99mTc-NM-01 Shanghai, China, March 30th, 2018. NanoMab today announced dosing of the first patients for its FIH of 99mTc-NM-01 in patients with non-small cell lung cancer at SGH. 99mTc-NM-01 is a camelid single domain antibody-based imaging agent for the non-invasive and [...]
Date: Feb 27th, 2018 NanoMab To Initiate FIH for 99mTc-NM-01 at SGH Shanghai, China, February 27th, 2018. NanoMab announced that it has decided to initiate FIH with NM-01, which is the company’s non-small cell lung cancer (NSCLC) program. The kick off meeting was held at Shanghai General Hospital (SGH). The primary objective of this [...]